Welcome to LookChem.com Sign In|Join Free
  • or
ETHYL IMIDAZO[1,2-A]PYRIMIDINE-3-CARBOXYLATE is a heterocyclic chemical compound with the formula C9H10N2O2. It features an imidazole ring fused with a pyrimidine ring and an ethyl ester group attached to the carboxylate functional group. ETHYL IMIDAZO[1,2-A]PYRIMIDINE-3-CARBOXYLATE is of interest to chemists and pharmaceutical researchers due to its structural and functional properties, and it has potential pharmaceutical uses as an intermediate in the synthesis of various pharmaceutical compounds and as a building block in organic chemistry for the synthesis of other complex molecules.

64951-07-1

Post Buying Request

64951-07-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

64951-07-1 Usage

Uses

Used in Pharmaceutical Industry:
ETHYL IMIDAZO[1,2-A]PYRIMIDINE-3-CARBOXYLATE is used as an intermediate in the synthesis of various pharmaceutical compounds for its potential therapeutic applications.
Used in Organic Chemistry:
ETHYL IMIDAZO[1,2-A]PYRIMIDINE-3-CARBOXYLATE is used as a building block for the synthesis of other complex molecules, contributing to the development of new chemical entities with potential applications in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 64951-07-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,9,5 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 64951-07:
(7*6)+(6*4)+(5*9)+(4*5)+(3*1)+(2*0)+(1*7)=141
141 % 10 = 1
So 64951-07-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H9N3O2/c1-2-14-8(13)7-6-11-9-10-4-3-5-12(7)9/h3-6H,2H2,1H3

64951-07-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl imidazo[1,2-a]pyrimidine-3-carboxylate

1.2 Other means of identification

Product number -
Other names ethyl imidazo[1,2-a]pyrimidine-3-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:64951-07-1 SDS

64951-07-1Relevant academic research and scientific papers

Discovery of potent colony-stimulating factor 1 receptor inhibitors by replacement of hinge-binder moieties

Lee, Jung Wuk,Park, Jiwon,Kim, Jina,Kim, Jihyung,Choi, Changyu,Min, Kyung Hoon

, (2021/03/14)

Tumor-associated macrophages (TAMs) are predominantly associated with tumor growth. Colony-stimulating factor 1 receptor (CSF1R) acts as a key regulator of TAM survival and differentiation and is a molecular target for cancer therapies. Herein, novel CSF1

New geldanamycin derivatives with anti Hsp properties by mutasynthesis

Hermane, Jekaterina,Eichner, Simone,Mancuso, Lena,Schr?der, Benjamin,Sasse, Florenz,Zeilinger, Carsten,Kirschning, Andreas

supporting information, p. 5269 - 5278 (2019/06/07)

Mutasynthetic supplementation of the AHBA blocked mutant strain of S. hygroscopicus, the geldanamycin producer, with 21 aromatic and heteroaromatic amino acids provided new nonquinoid geldanamycin derivatives. Large scale (5 L) fermentation provided four new derivatives in sufficient quantity for full structural characterisation. Among these, the first thiophene derivative of reblastatin showed strong antiproliferative activity towards several human cancer cell lines. Additionally, inhibitory effects on human heat shock protein Hsp90α and bacterial heat shock protein from H. pylori HpHtpG were observed, revealing strong displacement properties for labelled ATP and demonstrating that the ATP-binding site of Hsps is the target site for the new geldanamycin derivatives.

THERAPEUTIC INHIBITORY COMPOUNDS

-

Paragraph 00266, (2018/03/26)

Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma kallikrein. Furthermore, the subject compounds and compositions are useful for the treatment of diseases wherein the inhibition of plasma kallikrein inhibition has been implicated, such as angioedema and the like.

Hypervalent iodine(III) promoted direct synthesis of imidazo[1,2-a] pyrimidines

Qian, Guangyin,Liu, Bingxin,Tan, Qitao,Zhang, Siwen,Xu, Bin

, p. 4837 - 4843 (2014/08/05)

An efficient and mild synthesis of imidazo[1,2-a]pyrimidine derivatives has been developed from readily available pyrimidyl arylamines or enamines through a hypervalent iodine-promoted intramolecular C-H bond cycloamination reaction. This protocol allows for the facile construction of biologically active bicyclic imidazo[1,2-a]pyrimidine skeletons as well as other imidazo[1,2-a]-type fused heterocycles.

Discovery of 6-(Aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2- α]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitors

Meng, Wei,Brigance, Robert P.,Chao, Hannguang J.,Fura, Aberra,Harrity, Thomas,Marcinkeviciene, Jovita,O'connor, Stephen P.,Tamura, James K.,Xie, Dianlin,Zhang, Yaqun,Klei, Herbert E.,Kish, Kevin,Weigelt, Carolyn A.,Turdi, Huji,Wang, Aiying,Zahler, Robert,Kirby, Mark S.,Hamann, Lawrence G.

experimental part, p. 5620 - 5628 (2010/10/20)

Continued structure-activity relationship (SAR) exploration within our previously disclosed azolopyrimidine containing dipeptidyl peptidase-4 (DPP4) inhibitors led us to focus on an imidazolopyrimidine series in particular. Further study revealed that by replacing the aryl substitution on the imidazole ring with a more polar carboxylic ester or amide, these compounds displayed not only increased DPP4 binding activity but also significantly reduced human ether-à-go-go related gene (hERG) and sodium channel inhibitory activities. Additional incremental adjustment of polarity led to permeable molecules which exhibited favorable pharmacokinetic (PK) profiles in preclinical animal species. The active site binding mode of these compounds was determined by X-ray crystallography as exemplified by amide 24c. A subsequent lead molecule from this series, (+)-6-(aminomethyl)-5-(2,4-dichlorophenyl)-N-(1-ethyl-1H- pyrazol-5-yl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamide (24s), emerged as a potent, selective DPP4 inhibitor that displayed excellent PK profiles and in vivo efficacy in ob/ob mice.

AZOLOPYRIMIDINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND METHODS

-

Page/Page column 83, (2008/06/13)

Compounds are provided having the formula (I): Formula (I) wherein R, X, Y, A and n are as defined herein.

The Chemistry of 5-Oxodihydroisoxazoles. VIII. Photolysis of 2-(Heterocyclyl)isoxazol-5(2H)-ones

Prager, Rolf H.,Singh, Yogendra,Weber, Ben

, p. 1249 - 1262 (2007/10/02)

Photolysis of 2-(heterocyclyl)isoxazol-5(2H)-ones occurs readily at 300 nm.In alcohol the products are the corresponding 2-alkoxy-3-heterocyclylaminoacrylates, and, in the presence of 1 M trifluoroacetic acid, the corresponding imidazole annulated heteroc

Research on heterocyclic compounds. XXXII. Synthesis and cyclooxygenase-independent antiinflammatory and analgesic activity of imidazopyrimidine derivatives

Abignente, E.,Sacchi, A.,Laneri, S.,Rossi, F.,D'Amico, M.,et al.

, p. 279 - 286 (2007/10/02)

The synthesis of a group of imidazopyrimidine-2-carboxylic esters, acids and amides is described.The structures of the new compounds are supported by 1H- and 13C-NMR spectra.These compounds were tested in vivo for their antiinflammatory and analgesic activities as well as for their ulcerogenic action.The ester 5b, the acid 6c and the amide 7a showed antiinflammatory action in the rat paw edema (ca. 1/3 x indomethacin), while almost all compounds displayed significant analgesic activity in the acetic acid writhing test, particularly the 5-chloro-7-methyl derivatives 5a, 6a and 7a (ca 1/5 x indomethacin).All new compounds were found to be lacking in inhibitory activity on cyclooxygenase in vitro. imidazopyrimidines / antiinflammatory activity / analgesic activity / ulcerogenic activity / cyclooxygenase inhibition

The chemistry of 5-oxodihydroisoxazoles VII1 conversion of heterocyclylisoxazol-5(2H)-ones to imidazoles by flash vacuum pyrolysis

Prager, Rolf H.,Singh, Yogendra

, p. 8147 - 8158 (2007/10/02)

A number of 5-oxo-2,5-dihydroisoxazoles, substituted with nitrogen heterocycles at N-2, have been subjected to flash vacuum pyrolysis. Annelated imidazoles are obtained in excellent yields, and are presumed to arise by intramolecular cyclisation of an imi

Antifungal activity in vitro of some imidazopyrimidine derivatives

Rival, Y,Grassy, G,Taudou, A,Ecalle, R

, p. 13 - 18 (2007/10/02)

In regard to fungicidal activity of imidazole ring found in chemical compounds such as econazole, a series of 42 diversely substituted imidazopyrimidines was synthetized and examined for its antifungal activity in several species.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 64951-07-1